Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Alnylam Pharmaceuticals (ALNY) Q1 2026 Earnings
ALNY
12
Feb
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.89
0.02
0.93
1.84
Details
Expected EPS
1.15591
Actual EPS
0.82
Surprise EPS
-0.34
Surprise Percent
+29.06%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of 0.82 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login